Browse Pet Safety Reports
18,045 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,045 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,045 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Dec 6, 2023 | Horse | Pony (unspecified) | Pentobarbital Sodium And Phenytoin So... | Lack of efficacy - NOS | Euthanized |
| Dec 6, 2023 | Horse | Warmblood (unspecified) | Polysulfated Glycosaminoglycan | Injection site swelling; Muscle stiffness | Recovered/Normal |
| Dec 6, 2023 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Dec 6, 2023 | Horse | Welsh Mountain Pony | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Underdose | Ongoing |
| Dec 5, 2023 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Dec 4, 2023 | Horse | Quarter Horse | Banamine Paste | Heavy sweating; Lying down; Increased respiratory rate; Not eating; Gut sound... | Ongoing |
| Dec 4, 2023 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Heavy sweating; Lying down; Increased respiratory rate; Not eating; Gut sound... | Ongoing |
| Dec 4, 2023 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Dec 2, 2023 | Horse | Quarter Horse | Praziquantel;Moxidectin | Neutropenia; Other abnormal test result NOS; Lethargy (see also Central nervo... | Ongoing |
| Dec 1, 2023 | Horse | Quarter Horse | Pergolide Mesylate | Hyperactivity; Anorexia; Lack of efficacy - NOS; High adrenocorticotropic (AC... | Outcome Unknown |
| Dec 1, 2023 | Horse | Welsh Pony | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S) | Ongoing |
| Dec 1, 2023 | Horse | Mustang | Monensin Sodium | Colic; Tongue disorder NOS; Swallowing disorder NOS; Digestive tract disorder... | Ongoing |
| Dec 1, 2023 | Horse | Rocky Mountain Horse | Ceftiofur Crystalline Free Acid | Injection site inflammation; Fever | Ongoing |
| Nov 30, 2023 | Horse | Paint | Detomidine Hydrochloride | Swollen limb; Musculoskeletal pain; Underdose | Recovered/Normal |
| Nov 30, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Lack of efficacy - NOS | Outcome Unknown |
| Nov 30, 2023 | Horse | Quarter Horse | Pergolide Mesylate | Lack of efficacy - NOS | Outcome Unknown |
| Nov 30, 2023 | Horse | Hanovarian | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Nov 29, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Nov 28, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 27, 2023 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 25, 2023 | Horse | Paint | Polysulfated Glycosaminoglycan | Nasal bleeding | Recovered/Normal |
| Nov 24, 2023 | Horse | Tennessee Walking Horse | Ivermectin; Praziquantel | Oral swelling; Scale; Swollen tongue; Skin scab; Anaphylactic-type reaction | Recovered/Normal |
| Nov 24, 2023 | Horse | Horse (unknown) | Ivermectin; Praziquantel | Colic | Recovered/Normal |
| Nov 23, 2023 | Horse | Thoroughbred | Firocoxib | Lack of efficacy - NOS; Oral ulceration | Outcome Unknown |
| Nov 23, 2023 | Horse | Quarter Horse | Diclazuril Oral Pellets | Lack of efficacy (protozoa) - NOS | Ongoing |
| Nov 23, 2023 | Horse | Quarter Horse, Horse (unknown) | Ceftiofur Crystalline Free Acid | Injection site swelling | Recovered/Normal; Outcome Unknown |
| Nov 23, 2023 | Horse | Quarter Horse | Pergolide Mesylate | Dry skin; Increased skin sensitivity | Outcome Unknown |
| Nov 19, 2023 | Horse | Quarter Horse | Clodronate Disodium | Lameness; Pawing; Decreased appetite; Injection site pain | Recovered/Normal |
| Nov 17, 2023 | Horse | Horse (unknown) | Ivermectin; Praziquantel | Generalised allergic reaction NOS | Outcome Unknown |
| Nov 16, 2023 | Horse | Quarter Horse, Horse (unknown) | Pentosan Polysulfate Sodium | Dull; Decreased appetite | Outcome Unknown |
| Nov 16, 2023 | Horse | Thoroughbred | Omeprazole | Anorexia; Lethargy (see also Central nervous system depression in Neurological) | Recovered/Normal |
| Nov 16, 2023 | Horse | Warmblood (unspecified) | Omeprazole | Comedo/blackhead | Ongoing |
| Nov 14, 2023 | Horse | Pony (unspecified) | Omeprazole | Gastric ulcer; Lack of efficacy - NOS | Outcome Unknown |
| Nov 14, 2023 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Nov 14, 2023 | Horse | Horse (other) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 14, 2023 | Horse | Horse (unknown) | Praziquantel;Moxidectin | Diarrhoea | Outcome Unknown |
| Nov 13, 2023 | Horse | Thoroughbred | Flunixin Meglumine Injectable | Pruritus; Pale mucous membrane; Lying down; Uncomfortable; Discomfort NOS; An... | Ongoing |
| Nov 13, 2023 | Horse | Horse (unknown) | Ketamine Hydrochloride | Lack of efficacy - NOS | Outcome Unknown |
| Nov 13, 2023 | Horse | Thoroughbred | Ceftiofur Crystalline Free Acid | Pruritus; Pale mucous membrane; Lying down; Uncomfortable | Ongoing |
| Nov 12, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 10, 2023 | Horse | Quarter Horse | Ceftiofur Sodium | Hives (see also Skin) | Recovered/Normal |
| Nov 9, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 9, 2023 | Horse | Quarter Horse | Ciclesonide | Behavioural disorder NOS | Outcome Unknown |
| Nov 9, 2023 | Horse | Horse (unknown) | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Nov 8, 2023 | Horse | Thoroughbred | Ceftiofur Sodium | Enlarged lymph node (localised); Fever; Neutrophilia; Decreased red blood cel... | Ongoing |
| Nov 8, 2023 | Horse | Quarter Horse | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Nov 7, 2023 | Horse | Arab | Pergolide Mesylate | Behavioural disorder NOS | Outcome Unknown |
| Nov 7, 2023 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 7, 2023 | Horse | Saddlebred - American | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 6, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Aneurism | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.